Fleboton hard capsules 300 mg. №50


Manufacturer: Bulgaria

Symptomatic treatment: pre-varicose and varicose syndrome; superficial thrombophlebitis, phlebitis and post-phlebitis conditions; chronic venous insufficiency; swelling and pain in injuries and varicose veins.



Fleboton №50 Composition of the medicinal product:

active substance: 1 capsule contains 300 mg troxerutin
excipients: lactose monohydrate, anhydrous colloidal silicon dioxide, macrogol, magnesium stearate, hard gelatin capsule (gelatin, quinoline yellow (E 104), sunset yellow FCF (E 110), titanium dioxide (E 171)).

Fleboton №50 Dosage form.

Hard capsules. Hard cylindrical, opaque yellow gelatin capsules.

Shows anti-inflammatory and antioxidant effects and inhibits hyaluronidase. Prevents oxidation of hyaluronic, ascorbic acid and adrenaline, suppresses lipid peroxidation. Troxerutin reduces capillary permeability and fragility and prevents damage to the basement membrane of endothelial cells by various factors, and in addition, it also has a membrane stabilizing, antihemorrhagic, detoxic, antiallergic, venotonic effect. Reduces edema, improves trophism and other symptoms associated with venous insufficiency or impaired outflow of lymphatic fluid.

Fleboton №50 Indications for use.

For the symptomatic treatment of such diseases:

prevaricose and varicose syndrome, varicose ulcers
superficial thrombophlebitis, phlebitis and postphlebitis conditions
chronic venous insufficiency
hemorrhoidal disease
diabetic retinopathy (as part of complex therapy)
swelling and pain from injuries and varicose veins varicose dermatitis
combined treatment of contusions, sprains, dislocations, symptoms of muscle cramps (convulsive contraction of the calf muscles).


Hypersensitivity to the active substance or to any of the excipients.
Peptic ulcer and duodenal ulcer, chronic gastritis (in the acute phase).

Appropriate safety precautions for use.

Patients with edema of the lower extremities as a result of diseases of the heart, kidneys or liver should not use the drug, because it is ineffective in these conditions.
The drug should be used with caution in patients with severe liver and gallbladder diseases. Since the drug irritates the stomach lining, it should be taken with food.
Patients with galactose intolerance, Laap lactase deficiency or glucose-galactose malabsorption should not use the drug.
E 110 dye can cause allergic reactions.

Special warnings.

Application during pregnancy or lactation.
In accordance with general clinical practice, use in the first trimester of pregnancy is not recommended.
In the II and III trimester, as well as during lactation, it is recommended to use the drug as directed by a doctor, when the expected benefit to the mother from its use outweighs the possible risk to the fetus.

The ability to influence the reaction rate when driving or operating other mechanisms.

Phleboton does not affect the reaction rate when driving or operating other mechanisms.


There is no data on the use of the drug in children.

Method of administration and dosage.

Take the capsules with meals with a glass of water.


Symptoms The manifestations of adverse reactions may increase.
Treatment. Stop taking the drug. It is recommended to induce vomiting or gastric lavage and symptomatic treatment. Peritoneal dialysis can be prescribed if necessary.

Side effects.

Adverse reactions are rarely observed during treatment. In some cases, you may experience:
From the immune system

From the nervous system

From the side of the vessels

From the gastrointestinal tract

On the part of the skin and subcutaneous tissue

General disorders and effects at the site of application

Interaction with other medicinal products and other types of interactions.

There are no data on clinically significant drug interactions with Phleboton.

Shelf life.

5 years.

Storage conditions.


10 capsules in a blister of PVC film / aluminum foil, 5 blisters in a cardboard box.

Vacation category.

Over the counter.